All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F17%3A43913343" target="_blank" >RIV/00216208:11120/17:43913343 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/17:N0000105

  • Result on the web

    <a href="http://dx.doi.org/10.1159/000475604" target="_blank" >http://dx.doi.org/10.1159/000475604</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1159/000475604" target="_blank" >10.1159/000475604</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids

  • Original language description

    Background/Aims: Branched chain amino acids (BCAAs) are known to exert an insulinotropic effect. Whether this effect is mediated by incretins (glucagon like peptide 1 [GLP-1] or glucose-dependent insulinotropic peptide [GIP]) is not known. The aim of this study was to show whether an equivalent dose of BCAA elicits a greater insulin and incretin response when administered orally than intravenously (IV). Methods: Eighteen healthy, male subjects participated in 3 tests: IV application of BCAA solution, oral ingestion of BCAA and placebo in an equivalent dose (30.7 +- 1.1 g). Glucose, insulin, C-peptide, glucagon, GLP-1, GIP, valine, leucine and isoleucine concentrations were measured. Results: Rise in serum BCAA was achieved in both BCAA tests, with incremental areas under the curve (iAUC) being 2.1 times greater for IV BCAA compared with those of the oral BCAA test (p &lt; 0.0001). Oral and IV BCAA induced comparable insulin response greater than placebo (240 min insulin iAUC: oral 3,411 +- 577 vs. IV 2,361 +- 384 vs. placebo 961.2 +- 175 pmol/L, p = 0.0006). Oral BCAA induced higher GLP-1 (p &lt; 0.0001) and GIP response (p &lt; 0.0001) compared with the IV or placebo. Glucose levels declined significantly (p &lt; 0.001) in the same pattern during both BCAA tests with no change in the placebo group. Conclusions: An equivalent dose of BCAA elicited a comparable insulin and greater incretin response when administered orally and not when administered through IV. We conclude that insulinotropic effects of BCAA are partially incretin dependent.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30202 - Endocrinology and metabolism (including diabetes, hormones)

Result continuities

  • Project

    <a href="/en/project/NT14416" target="_blank" >NT14416: Effect of branched-chain amino acids and saturated fatty acids on development of insulin resistance</a><br>

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Annals of Nutrition &amp; Metabolism

  • ISSN

    0250-6807

  • e-ISSN

  • Volume of the periodical

    70

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    10

  • Pages from-to

    293-302

  • UT code for WoS article

    000405094100005

  • EID of the result in the Scopus database

    2-s2.0-85020450478